Breaking News

FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement

Aims to enhance biotherapeutic development with enhanced galactosylation for improved protein quality, and antibody binding and function

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Irvine Scientific, Inc., a provider of optimization, development and manufacture of cell culture media and industrial cell culture solutions, introduced BalanCD Gal Supplement, a new formula developed to increase galactosylation in biotherapeutic development, to help achieve desired glycan profiles for improved product quality and antibody efficacy.   Glycosylation is a critical aspect in development and optimization of protein-based therapeutics and can significantly affect antibody ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters